Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kevin Michael Krause Insider Profile
4 Followers
Kevin Michael Krause, CSO at AN2 Therapeutics, Inc., holds 31.91K shares in AN2 Therapeutics, Inc. (Ticker: ANTX).
Kevin Michael Krause has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Kevin Michael Krause's holdings
Insider Roles
CSO
Roles that Kevin Michael Krause holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Kevin Michael Krause
Kevin Michael Krause's Trading History
List of latest transactions for each holding click on a transaction to see Kevin Michael Krause's performance on stock
You May Also Like
Kevin Michael Krause insider profile FAQ
What is the percentage of profitable transactions made by Kevin Michael Krause?
The percentage of profitable transactions made by Kevin Michael Krause is ―.
What is the average return per transaction made by Kevin Michael Krause?
The average return per transaction made by Kevin Michael Krause is ―.
What stocks does Kevin Michael Krause hold?
Kevin Michael Krause holds: ANTX stocks.
What was Kevin Michael Krause’s latest transaction?
Kevin Michael Krause latest transaction was an Uninformative Buy of ―.
What was Kevin Michael Krause's most profitable transaction?
Kevin Michael Krause’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Kevin Michael Krause's role in AN2 Therapeutics, Inc.?
Kevin Michael Krause's role in AN2 Therapeutics, Inc. is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.